Fig. 2
From: GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer
Screening for drug resistance-associated prognostic genes in prostate cancer. A Venn diagram of docetaxel resistance GEO dataset. B Venn diagram of enzalutamide resistance GEO dataset. C Venn diagram of drug resistance co-expression genes. D Heat map of drug resistance-associated prognostic genes. E Histogram of expression differences. F–J Progress free interval analysis, including PARVA, GAD1, ATP2B4, NFIB and SH3BGRL. K GO-KEGG analysis